SGEM#514: Every Time You Go Away (and survive alive for 90 days) – Is It Due To A Restricted Fluid Strategy with Early Vasopressors?

Early septic shock management requires balancing fluid resuscitation with vasopressor use to optimize patient outcomes. The ARISE Fluids trial, involving 1,000 adult patients, demonstrates that a restrictive fluid strategy combined with early vasopressors yields no significant difference in 90-day survival or days alive and out of hospital compared to a more liberal fluid approach. Fixed volume mandates, such as the 30 mL/kg recommendation, lack robust evidence and may lead to fluid overload. Instead, clinicians should individualize hemodynamic support by titrating fluids to perfusion markers and initiating vasopressors early when necessary. Dr. Aaron Skolnik, a multidisciplinary intensivist at the Mayo Clinic, emphasizes that bedside clinical judgment remains superior to algorithmic protocols. Ultimately, the priority is early recognition, timely antimicrobials, and source control, rather than adhering to rigid, one-size-fits-all resuscitation bundles.